From December 31, 2023 to March 30, 2024, the company has repurchased 1,428,242 shares, representing 0.61% for $102.19 million. With this, the company has completed the repurchase of 10,419,336 shares, representing 4.28% for $753.72 million under the buyback announced on September 23, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
74.34 USD | +0.33% |
|
+0.19% | +3.90% |
07-02 | Evercore ISI Adjusts Price Target on Hologic to $76 From $78, Maintains In-line Rating | MT |
06-27 | Stephens Initiates Coverage on Hologic With Overweight Rating, $87 Price Target | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.90% | 17.29B | |
+1.74% | 206B | |
+3.53% | 177B | |
+31.79% | 157B | |
+31.97% | 112B | |
+2.13% | 64.63B | |
+20.24% | 55.63B | |
-1.61% | 47.57B | |
-9.67% | 36.87B | |
-0.25% | 35.18B |
- Stock Market
- Equities
- HOLX Stock
- News Hologic, Inc.
- Tranche Update on Hologic, Inc.'s Equity Buyback Plan announced on September 23, 2022.